Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
NCT04470310
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
99
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Glimepiride
DRUG:
Alogliptin 25Mg Tab
DRUG:
Alogliptin-Pioglitazone 25 Mg-15 Mg Oral Tablet
Sponsor
Seoul National University Hospital